Carlos R. Bachier, MD

Carlos R. Bachier, MD, is the director of blood and marrow transplant research at Sarah Cannon Research Institute in Nashville, TN.

Articles by Carlos R. Bachier, MD

Evaluating the Feasibility of Liso-cel Administration in the Outpatient Setting

ByCarlos R. Bachier, MD

April 22nd 2020

Carlos R. Bachier, MD, discusses how an analysis of 3 clinical trials evaluating the efficacy of lisocabtagene maraleucel demonstrated the feasibility of outpatient administration of chimeric antigen receptor T-cell therapy.

Carlos R. Bachier, MD

Articles by Carlos R. Bachier, MD

Evaluating the Feasibility of Liso-cel Administration in the Outpatient Setting

Latest Updated Articles

Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways

FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL

Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC

JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update

LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors

Safusidenib Shows Robust, Ongoing Responses in Grade 2 IDH1-Mutant Glioma